CA
VRNA

CoreCap Advisors’s Verona Pharma VRNA Stock Holding History

CoreCap Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-285
Closed -$27K – 2952
2025
Q2 		$27K Hold
285
– – ﹤0.01% 1499
2025
Q1 		$18.1K Hold
285
– – ﹤0.01% 1579
2024
Q4 		$13.2K Sell
285
-194
-41% -$7.28K ﹤0.01% 1673
2024
Q3 		$13.8K Buy
+479
New +$11.8K ﹤0.01% 1688
2024
Q2 		– Sell
-657
Closed -$10.6K – 2587
2024
Q1 		$10.6K Buy
+657
New +$11.4K ﹤0.01% 1727
2022
Q4 		$15.7K Buy
+600
New +$7.99K ﹤0.01% 1383
2022
Q3 		– Sell
-600
Closed -$3K – 2071
2022
Q2 		$3K Buy
+600
New +$2.57K ﹤0.01% 1815
2022
Q1 		– Sell
-600
Closed -$4K – 2067
2021
Q4 		$4K Buy
+600
New +$3.06K ﹤0.01% 1830

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $7.94B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return